Lista de obras - Alba Espargaró - Dominio Público Uruguay

A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

scientific article published on 17 July 2019

Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils

artículo científico publicado en 2011

Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases

Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution

artículo científico publicado en 2015

Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods

scientific article published on 01 January 2019

Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states

artículo científico publicado en 2011

Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion

artículo científico publicado en 2009

Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.

artículo científico publicado en 2017

Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?

artículo científico publicado en 2015

Deciphering the role of the thermodynamic and kinetic stabilities of SH3 domains on their aggregation inside bacteria

artículo científico publicado en 2010

Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids.

artículo científico

Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case.

artículo científico publicado en 2007

Discovery of novel inhibitors of amyloid β-peptide 1-42 aggregation.

artículo científico publicado en 2012

Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation

artículo científico publicado en 2021

Effect of the surface charge of artificial model membranes on the aggregation of amyloid β-peptide

artículo científico publicado en 2012

Energy barriers for HET-s prion forming domain amyloid formation

artículo científico publicado en 2009

Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration.

artículo científico publicado en 2017

Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity

artículo científico publicado en 2016

In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time

artículo científico publicado en 2015

Inclusion bodies: Specificity in their aggregation process and amyloid-like structure

Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion

artículo científico publicado en 2016

Kinetic and thermodynamic stability of bacterial intracellular aggregates

artículo científico publicado en 2008

Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.

artículo científico publicado en 2015

Native structure protects SUMO proteins from aggregation into amyloid fibrils

artículo científico publicado el 25 de mayo de 2012

Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies

artículo científico publicado en 2015

Predicting the aggregation propensity of prion sequences

artículo científico publicado en 2015

Screening for amyloid aggregation: in-silico, in-vitro and in-vivo detection

artículo científico publicado en 2014

Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.

artículo científico publicado en 2014

Studies on bacterial inclusion bodies

artículo científico publicado en 2008

Study and selection of in vivo protein interactions by coupling bimolecular fluorescence complementation and flow cytometry.

artículo científico publicado en 2008

Temperature Dependence of the Aggregation Kinetics of Sup35 and Ure2p Yeast Prions

Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.

artículo científico publicado en 2014

The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case

artículo científico publicado en 2008

The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils

artículo científico publicado en 2010

Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation ⬇️

artículo científico publicado el 7 de agosto de 2012

Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors

artículo científico publicado en 2014

Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination

scientific article published on 05 May 2020

Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs

artículo científico publicado en 2016

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors

artículo científico publicado en 2012

Yeast prions form infectious amyloid inclusion bodies in bacteria

artículo científico publicado en 2012

Lista de obras de Alba Espargaró

A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils

Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases

Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution

Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods

Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states

Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion

Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.

Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?

Deciphering the role of the thermodynamic and kinetic stabilities of SH3 domains on their aggregation inside bacteria

Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids.

Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case.

Discovery of novel inhibitors of amyloid β-peptide 1-42 aggregation.

Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation

Effect of the surface charge of artificial model membranes on the aggregation of amyloid β-peptide

Energy barriers for HET-s prion forming domain amyloid formation

Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration.

Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity

In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time

Inclusion bodies: Specificity in their aggregation process and amyloid-like structure

Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion

Kinetic and thermodynamic stability of bacterial intracellular aggregates

Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.

Native structure protects SUMO proteins from aggregation into amyloid fibrils

Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies

Predicting the aggregation propensity of prion sequences

Screening for amyloid aggregation: in-silico, in-vitro and in-vivo detection

Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.

Studies on bacterial inclusion bodies

Study and selection of in vivo protein interactions by coupling bimolecular fluorescence complementation and flow cytometry.

Temperature Dependence of the Aggregation Kinetics of Sup35 and Ure2p Yeast Prions

Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.

The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case

The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils

Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation ⬇️

Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors

Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination

Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors

Yeast prions form infectious amyloid inclusion bodies in bacteria